ImageneBio, Inc.
IMA
$5.84
-$0.03-0.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.39% | 16.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.44% | 42.04% | |||
| Operating Income | 2.44% | -42.04% | |||
| Income Before Tax | 4.21% | -47.68% | |||
| Income Tax Expenses | 60.00% | 103.62% | |||
| Earnings from Continuing Operations | 4.15% | -53.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.15% | -53.72% | |||
| EBIT | 2.44% | -42.04% | |||
| EBITDA | 2.46% | -47.69% | |||
| EPS Basic | 33.51% | -53.32% | |||
| Normalized Basic EPS | 33.59% | -47.36% | |||
| EPS Diluted | 33.51% | -53.32% | |||
| Normalized Diluted EPS | 33.59% | -47.36% | |||
| Average Basic Shares Outstanding | 44.16% | 0.27% | |||
| Average Diluted Shares Outstanding | 44.16% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||